Facilitated By

San Antonio Medical Foundation

News

  • Two Texas companies among initial public offerings scheduled to debut this week

    Business: Phase 2 biotech developing therapies for neurodevelopmental disorders. Rackspace Technology – San Antonio, Texas, 33.5 million shares ...

  • Does a plastic face shield protect you and others as well as a mask?

    But the author of the study, William Lindsley, a research biomedical engineer at the National Institute for Occupational Safety and Health, told NBC ...

  • The Latest on the Coronavirus Vaccine

    ... is being co-developed by researchers at NIH's National Institute of Allergy and Infectious Diseases (NIAID) and the biotech company Moderna, Inc.

  • Jefferson: Weaning SA off the low-wage economy — if the pandemic doesn't kick-start change ...

    Like many other CEOs in San Antonio, Bret Piatt is doing the responsible thing. ... SA Works also examined hiring in health care and the biosciences, ...

  • Merck ups outlook, turns profit during global vaccine hunt

    The company bought Austrian vaccine maker Themis Biosciences this year to gain rights to its experimental COVID-19 vaccine. Human tests should ...